Verastem Inc. buy secretariat
Start price
08.08.20
/
50%
€15.29
Target price
04.11.21
€24.00
Performance (%)
148.67%
End price
03.06.21
€38.02
Summary
This prediction ended on 03.06.21 with a price of €38.02. With a performance of 148.67% the BUY prediction by secretariat was a big success. secretariat has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Verastem Inc. | -15.566% | -15.566% | 113.706% | -67.852% |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
According to secretariat what are the pros and cons of Verastem Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by secretariat for this prediction
In the thread Verastem Inc. diskutieren
Buy Verastem Inc.
125 Millionen Cash in Dollar plus der Verkauf der
Copiktra-Rechte für insgesamt 311 Millionen Dollar Cash im voraus 70 Millionen Dollar
MKT 200 Millionen Dollar Leider verbrennen die auch pro Quartal 25 Millionen Dollar aber irgendwann ist der Boden erreicht Hoffentlich